Realcan Pharmaceutical Group Co (SZSE:002589) 3-Year EBITDA Growth Rate : -40.70% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Realcan Pharmaceutical Group Co 3-Year EBITDA Growth Rate?

Realcan Pharmaceutical Group Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.06.

During the past 3 years, the average EBITDA Per Share Growth Rate was -40.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Realcan Pharmaceutical Group Co was 72.20% per year. The lowest was -40.70% per year. And the median was 21.60% per year.

Competitive Comparison of Realcan Pharmaceutical Group Co's 3-Year EBITDA Growth Rate

For the Medical Distribution subindustry, Realcan Pharmaceutical Group Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Realcan Pharmaceutical Group Co's 3-Year EBITDA Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Realcan Pharmaceutical Group Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Realcan Pharmaceutical Group Co's 3-Year EBITDA Growth Rate falls into.

Realcan Pharmaceutical Group Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Realcan Pharmaceutical Group Co (SZSE:002589) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Realcan Pharmaceutical Group Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Realcan Pharmaceutical Group Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Realcan Pharmaceutical Group Co (SZSE:002589) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Realcan Pharmaceutical Group Co Ltd (SZSE:002589) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 326, Airport Road, Zhifu District, Shandong Province, Yantai, CHN, 264004

Website

http://www.realcan.cn

Realcan Pharmaceutical Group Co Ltd is a Chinese company engaged in direct pharmaceuticals distribution services. The company's main business is divided into the Drug, vaccine, medical device circulation service; Medical industry third-party logistics; Medical information service; Medical logistics service; Chinese medicine plate; Hospital management sector; Medical industry research and development production sector; and Medical industry financial sector.

Realcan Pharmaceutical Group Co (SZSE:002589) Headlines

No Headlines